ENFOQUS

Serial Number 98416390
732

Registration Progress

Application Filed
Feb 22, 2024
Under Examination
Jul 16, 2024
Approved for Publication
May 21, 2024
Published for Opposition
May 21, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jul 16, 2026 212 days

Trademark Image

ENFOQUS

Basic Information

Serial Number
98416390
Filing Date
February 22, 2024
Published for Opposition
May 21, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Nov 14, 2025
Application
Pending
Classes
005

Rights Holder

Cingulate Therapeutics LLC

16
Address
1901 W 47th Place, Suite 310
Kansas City, KS 66205

Ownership History

Cingulate Therapeutics LLC

Original Applicant
16
Kansas City, KS

Cingulate Therapeutics LLC

Owner at Publication
16
Kansas City, KS

Legal Representation

Attorney
Susan Neuberger Weller

USPTO Deadlines

Next Deadline
212 days remaining
NOA E-Mailed - SOU Required
Due Date
July 16, 2026
Extension Available
Until January 16, 2027

Application History

26 events
Date Code Type Description Documents
Nov 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 14, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 14, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 14, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 10, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 10, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 27, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 26, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 26, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 16, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 21, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 1, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 16, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 12, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 12, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 12, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 29, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 29, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 29, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 29, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 22, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 22, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)

Classification

International Classes
005